|
BALTIMORE, MD—June 18, 2014—Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), is pleased to announce the availability of a live, complimentary CME activity in multiple myeloma (MM), Clinical Conversations in Multiple Myeloma: Improving Treatment Through Personalized Education.
In each customized teleconference, participants speak with a nationally recognized thought leader in MM and receive answers to their specific questions on managing patients with MM. During these personalized, CME-certified teleconferences, faculty present information related to optimizing treatment selection for patients with newly diagnosed and relapsed or refractory MM and focus on the unique clinical challenges and educational needs of each participant.
“In the past decade, the treatment of MM has evolved at a rapid pace, leading to improved patient outcomes,” said Sagar Lonial, MD, professor and vice chair of Clinical Affairs at Emory University School of Medicine in
Atlanta, GA. “Because of these advances, selecting agents in the absence of direct-comparator trials can become challenging. These personalized teleconferences help guide hematologist/oncologists on individualizing treatment plans to maximize outcomes and minimize adverse events.”
The teleconferences are being held on the following dates:
Monday, June 23—3:00 PM ET, 3:30 PM ET, 4:00 PM ET, and 4:30 PM ET
Thursday, June 26—12:30 PM ET and 1:00 PM ET
Friday, June 27—3:30 PM ET, 4:00 PM ET, and 4:30 PM ET
Wednesday, July 2—1:00 PM ET, 1:30 PM ET, 2:00 PM ET, 2:30 PM ET, 3:00 PM ET, 3:30 PM ET, 4:00 PM ET, and 4:30 PM ET
Thursday, July 3—4:00 PM ET, 4:30 PM ET, 5:00 PM ET, and 5:30 PM ET
Tuesday, July 8—7:00 PM ET
Wednesday, July 9—7:00 PM ET
Monday, July 14—12:00 PM ET, 12:30 PM ET, and 1:00 PM ET
Tuesday, July 15—7:00 PM ET
Wednesday, July 16—7:00 PM ET
Thursday, July 17—7:00 PM ET
Friday, July 18—6:00 AM ET, 6:30 AM ET, 7:00 AM ET, 7:30 AM ET, 8:00 AM ET, and 8:30 AM ET
Tuesday, July 22—7:00 PM ET
Wednesday, July 23—7:00 PM ET
Thursday, July 24—7:00 PM ET
Monday, July 28—3:00 PM ET, 3:30 PM ET, 4:00 PM ET, 4:30 PM ET, 5:00 PM ET, and 5:30 PM ET
Registration is complimentary, and calls are currently being scheduled. Interested hematologist/oncologists can register here.
FACULTY
 |
|
Rafael Fonseca, MD
Getz Family Professor of Cancer
Chair, Department of Medicine
Mayo Clinic
Scottsdale, AZ
|
 |
|
Sagar Lonial, MD
Professor and Vice Chair of Clinical Affairs
Department of Hematology and Medical Oncology
Director of Translational Research, B-Cell Malignancy Program
Winship Cancer Institute
Emory University School of Medicine
Atlanta, GA
|
For more information, visit www.Med-IQ.com/a780, call (toll-free) 866 858 7434, or e-mail info@med-iq.com.
This activity is supported by educational grants from Celgene Corporation, Millennium: The Takeda Oncology Company, and Onyx Pharmaceuticals.
|
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
As a leader in the CME industry, Med-IQ has delivered 32 performance improvement (PI) and quality improvement (QI) initiatives that make use of systems-based training such as Crew Resource Management (CRM) to improve team performance and patient outcomes. These initiatives have achieved improvement in healthcare provider performance, quality of care, and patient outcomes. Med-IQ's work in performance and quality education and training have been published 27 times in peer-reviewed journals and has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact:
|
close
